Clinical Trial Update: Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for aripiprazole (Abilify) in children with Attention-Deficit/Hyperactivity Disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED